NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
NEXGEL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$5.80+0.21 (+3.76%)
Close on Oct 19, 2026
- Market cap
- $52.28M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$46.20 (−88.85%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
NEXGEL, INC. grew revenue 3.4% to $12.07M over the twelve months to Jun 30, 2026. Free cash flow was -$1.38M.
Revenue
$12.07M
+3.4% vs. a year earlier
Operating income
-$5.40M
TTM Q2 2026
Free cash flow
-$1.38M
FY2025
EPS, diluted
-$0.71
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $52.28M
- P/E ratio
- –
- Price to sales
- 4.33
- Price to book
- 10.56
- Dividend yield
- –
- Free cash flow yield
- -2.64%
Fundamentals
- Revenue
- $12.07M
- Net income
- -$6.19M
- EPS, diluted
- -$0.71
- Free cash flow
- -$1.38M
- Book value per share
- $0.55
- Diluted shares
- 9M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$12.07M+3.4% YoY
Gross profit
$4.23M-9.5% YoY
Operating income
-$5.40M
Net income
-$6.19M
EPS, diluted
-$0.71
Free cash flow
–
Reported periodTrailing twelve months